MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Long-term follow up of unilateral focused ultrasound subthalamotomy for the treatment of motor features in asymmetric PD

    J. Máñez-Miró, R. Martinez-Fernandez, M. Del álamo, F. Hernandez-Fernandez, R. Rodríguez-Rojas, J. Pineda-Pardo, F. Alonso-Frech, L. Vela-Desojo, J. Obeso (Móstoles-Madrid, Spain)

    Objective: To report long-term outcome of unilateral MR-guided focused ultrasound(MRgFUS) subthalamotomy for the treatment of PD cardinal motor features. Background: The development of MRgFUS as…
  • 2019 International Congress

    Are transventricular approaches associated with increased haemorrhage in functional stereotactic neurosurgery? A comparative study on 550 patients

    J. Runge, A. Saryyeva, C. Blahak, C. Schrader, H. Bäzner, HH. Capelle, M. Abdallat, M. Wolf, TM. Kinfe, JK. Krauss (Hannover, Germany)

    Objective: We investigate the comparative occurence of haemorrhage with or without transventricular apporaches in a large series of patients operated over two decades. Background: Accurate…
  • 2019 International Congress

    Transcranial MR guided FUS thalamotomy in essential tremor: a comprehensive lesion characterization

    D. Urso, J. Pineda-Pardo, R. Martínez-Fernández, R. Rodríguez-Rojas, M. Del-Alamo, P. Millar-Vernetti, JU. Mañez, F. F. Hernández-Fernández, E. de Luis-Pastor, L. Vela, JA. Obeso (Móstoles, Spain)

    Objective: To report on radiological and topographical features of the lesion observed at 24-hours and 3-months following Transcranial MR guided FUS (tcMRgFUS) thalamotomy in a…
  • 2019 International Congress

    Effects of three different physical therapies in body composition of Parkinson’s disease

    AOF. Fagundes, EPM. Monteiro, MSD. Delabary, APZ. Zanardi, MZC. Casal, VFM. Martins, MW. Wolffenbuttel, ANH. Haas, FGM. Martinez, LPT. Tartaruga (Porto Alegre, Brazil)

    Objective: Compare the effects of three physical therapies: dance (figure 1), deep water running (figure 2) and Nordic Walk (figure 3) in body composition of…
  • 2019 International Congress

    Evaluation of Device-Assisted Treatment using a wearable accelerometry wrist sensor

    A. Johansson, M. Lundgren, M. öthman, D. Nyholm (Stockholm, Sweden)

    Objective: To monitor the motor symptoms in patients with device-assisted therapy (DAT, defined as deep brain stimulation or infusion with apomorphine or levodopa) before and…
  • 2019 International Congress

    The development of a patient education and treatment programme for people with Parkinson’s disease

    P. Sloan, J. Farrell, J. Mchattie, L. Ebenezer, H. Evans (Bridgend, United Kingdom)

    Objective: To ensure we have a flexible education and treatment programme format, designed for people with Parkinson's disease (PWP), relevant to their time since diagnosis,…
  • 2019 International Congress

    Novel compound heterozygous mutations in the TSFM gene causes childhood-onset chorea

    CH. van Riesen, K. von Au, S. Biskup, A. Kühn, A. Kaindl, A. van Riesen (Berlin, Germany)

    Objective: To report the case of a young boy suffering from a severe hyperkinetic movement disorder caused by mutations in the recently described TSFM gene.…
  • 2019 International Congress

    Retronasal olfactory function in Parkinson’s disease

    E. Aubry-Lafontaine, C. Tremblay, P. Durand-Martel, N. Dupré, J. Frasnelli (Trois-Rivières, QC, Canada)

    Objective: The objective of this study was to compare orthonasal and retronasal olfactory function in PD patients and compare them to NPOD participants and to…
  • 2019 International Congress

    Gustatory Connectivity in Parkinson’s Disease Progression

    H. Chatterjee, G. Elumalai, N. Sewram, N. Osakwe (Georgetown, Guyana)

    Objective: To analyze the consistency of neural connections of the primary gustatory cortex (PGC), ranging from control group to progressive stages of Parkinson’s Disease (PD).…
  • 2019 International Congress

    Characteristics of the clinical and cerebral metabolism in Parkinson’s disease with atrophy in nucleus basalis of Meynert

    MY. Gang, T. Baba, Y. Hosokai, Y. Nishio, A. Kikuchi, K. Hirayama, T. Hasegawa, M. Aoki, A. Takeda, E. Mori, K. Suzuki (Sendai, Japan)

    Objective: We investigated characteristics of clinical and cerebral glucose metabolic abnormalities in Parkinson’s disease (PD) with atrophy in the nucleus basalis of Meynert (NBM). Background:…
  • « Previous Page
  • 1
  • …
  • 128
  • 129
  • 130
  • 131
  • 132
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley